Burgos L, Hernández F, Barrena S, Andres A M, Encinas J L, Leal N, Gamez M, Murcia J, Jara P, Lopez-Santamaria M, Tovar J A
Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain.
Eur J Pediatr Surg. 2008 Dec;18(6):372-4. doi: 10.1055/s-2008-1038900. Epub 2008 Nov 27.
Several variant techniques have been developed as alternatives to whole liver transplantation to improve size matching, timing, or simply to increase the pool of donors. The aim of this study was to assess the requirements of these techniques and their outcomes in a pediatric transplant program.
A retrospective analysis of children on the waiting list in the last 4 years was carried out. Data of patients who died while on the waiting list (WL) were recorded. Transplanted patients were divided according to the type of graft: whole liver, split, living donor and reduced liver. The analyzed outcome variables were: age, weight, UNOS status, cause of liver failure, complications and graft and patient survival. Comparisons between types of graft were performed by using Kaplan-Meier, log-rank, chi (2) and Kruskal-Wallis tests.
During the period studied, 116 children were listed for liver transplantation. Of these 116 children, nine (7.7 %) died after a mean period of 40.5 (5-175) days waiting for a suitable graft. Their median age at inclusion was 214 (35-1607) days, and median weight was 7.2 (12.3-3.6) kg. The cause of liver failure in this group was: 1 hemochromatosis, 1 hepatoblastoma, 2 biliary atresia, 2 acute liver failure, 2 primary non-function (PNF) and 1 chronic rejection. Liver transplantation was performed in 103 children: 25 (24 %) whole livers, 17 (16.5 %) split, 29 (28 %) living donor, 32 (31 %) reduced and 4 remain on the waiting list. Recipient age and weight were significantly lower in those receiving split and living donor than in those who given whole livers. Patient and graft survival were similar in all groups although there was a trend to lower graft survival in patients receiving whole livers. More than 50 % of patients with UNOS status I received a split graft and 5/6 children with hepatoblastoma underwent living donor transplantation. There were no differences in the rate of acute vascular complications, but long-term biliary complications were more frequent in split and living donor grafts.
As long as the goal of zero mortality for children on the waiting list is not achieved, variant techniques will be necessary in pediatric liver transplantation programs. Split and living donor were employed mostly to treat younger children and particularly those with a higher UNOS status. Children with tumors were treated mainly with living donor grafts. Variant techniques, which are absolutely necessary in a pediatric program, need to be improved in order to avoid long-term biliary complications.
已开发出几种不同的技术作为全肝移植的替代方法,以改善供肝与受体的大小匹配、移植时机,或者仅仅是为了增加供体库。本研究的目的是评估这些技术在儿童肝移植项目中的需求及其结果。
对过去4年中等待肝移植的儿童进行回顾性分析。记录了在等待名单(WL)上死亡的患者的数据。根据移植物类型将接受移植的患者分为:全肝、劈离式、活体供肝和减体积肝移植。分析的结果变量包括:年龄、体重、UNOS状态、肝衰竭原因、并发症以及移植物和患者的生存率。通过使用Kaplan-Meier法、对数秩检验、卡方检验和Kruskal-Wallis检验对不同类型的移植物进行比较。
在研究期间,有116名儿童被列入肝移植名单。在这116名儿童中,9名(7.7%)在平均等待40.5(5 - 175)天获得合适移植物后死亡。他们纳入时的中位年龄为214(35 - 1607)天,中位体重为7.2(12.3 - 3.6)kg。该组肝衰竭的原因如下:1例血色素沉着症、1例肝母细胞瘤、2例胆道闭锁、2例急性肝衰竭、2例原发性无功能(PNF)和1例慢性排斥反应。103名儿童接受了肝移植:25例(24%)为全肝移植,17例(16.5%)为劈离式肝移植,29例(28%)为活体供肝移植,32例(31%)为减体积肝移植,4例仍在等待名单上。接受劈离式和活体供肝移植的受者年龄和体重明显低于接受全肝移植的受者。所有组的患者和移植物生存率相似,尽管接受全肝移植的患者移植物生存率有降低的趋势。超过50%的UNOS I级患者接受了劈离式移植物,6例肝母细胞瘤患儿中有5例接受了活体供肝移植。急性血管并发症的发生率没有差异,但劈离式和活体供肝移植物的长期胆道并发症更为常见。
只要未实现等待名单上儿童零死亡率的目标,儿童肝移植项目就需要采用不同的技术。劈离式和活体供肝移植主要用于治疗年龄较小的儿童,特别是那些UNOS状态较高的儿童。患有肿瘤的儿童主要接受活体供肝移植。在儿童肝移植项目中绝对必要的不同技术需要改进,以避免长期胆道并发症。